D. E. Shaw & Co »

Avadel Pharmaceuticals shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Avadel Pharmaceuticals (AVDL) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Avadel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Avadel Pharmaceuticals held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avadel Pharmaceuticals by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.1M 161k 13.12
2024-06-30 $912k 65k 14.06

More positions owned by D. E. Shaw & Co

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Meta Platforms Cl A Put Option (META)
Amazon (AMZN)
Tesla Motors Put Option (TSLA)
Netflix Put Option (NFLX)
Booking Holdings Call Option (BKNG)
Advanced Micro Devices Put Option (AMD)
Broadcom Put Option (AVGO)
Eli Lilly & Co. Call Option (LLY)
Alphabet Cap Stk Cl A (GOOGL)
Bank of America Corporation (BAC)
Palantir Technologies Cl A (PLTR)
Citigroup Com New Put Option (C)

View all positions for D. E. Shaw & Co

Top funds holding Avadel Pharmaceuticals

Henderson Group
Jeffrey L. Gendell
BlackRock
BlackRock
Vanguard Group
Braidwell
Citadel Advisors
Wealth Effects
Two Seas Capital
Vestal Point Capital
Woodline Partners
Brandes Investment Partners
Tang Capital Management
Geode Capital Management
State Street Corporation

View all funds holding Avadel Pharmaceuticals